InvestorsHub Logo
icon url

DewDiligence

01/07/15 1:20 PM

#185605 RE: seschm #185604

MNTA and various generic-drug companies are up today, which is somewhat surprising insofar as the FDA panel’s endorsement of NVS’ Neupogen FoB was close to being a fait accompli (#msg-109613911).